Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical ...

Please provide your email address to receive an email when new articles are posted on . Currently, the standard-of-care fractionation schemes delivered concurrently with chemotherapy are conventional ...

The chemotherapy was the same in the NCIC and London studies, with cyclophosphamide, doxorubicin, and vincristine every 3 weeks alternating with etoposide and cisplatin (EP), for a total of six cycles ...

Thoracic outlet syndrome (TOS) is a group of conditions that occur when you have compressed nerves or blood vessels in the thoracic outlet. The thoracic outlet is the triangular space between your ...

Stage III non-small-cell lung cancer (NSCLC) represents a large patient population, accounting for approximately 30% of all NSCLC patients (van Meerbeeck, 2001). This stage has been intensively ...

Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...

Thoracic aneurysm open surgery is a treatment for a thoracic aortic aneurysm (TAA), a bulge in your aorta. The aorta, your body’s largest blood vessel, begins at your heart and extends into your ...

PHILADELPHIA — In a move that has given Phillies fans pause, ace pitcher Zack Wheeler was recently diagnosed with venous thoracic outlet syndrome (TOS) and is slated for season-ending decompression ...

Given the growing proportion of elderly people in Western societies and the increasing prevalence of chronic hypertension, the management of aneurysmal aortic disease is an ever growing challenge.

If nonsurgical treatments do not relieve a person’s thoracic outlet syndrome symptoms, a doctor may suggest surgery to relieve compression in the thoracic outlet. Surgery may include a first rib ...

The Barbara Ann Karmanos Cancer Institute in Detroit has added Dr. Khalil Choucair to its Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). He joins the team after […] ...